Try our beta test site
IMPORTANT: Listing of a study on this site does not reflect endorsement by the National Institutes of Health. Talk with a trusted healthcare professional before volunteering for a study. Read more...
4 studies found for:    22500948 [PUBMED-IDS]
Show Display Options
Rank Status Study
1 Completed
Has Results
Study of Extended Release Niacin/Laropiprant on Lipids (0524A-067)
Conditions: Primary Hypercholesterolemia;   Mixed Dyslipidemia
Interventions: Drug: Comparator: simvastatin;   Drug: niacin (+) laropiprant;   Drug: Comparator: atorvastatin calcium
2 Completed
Has Results
Extended Niacin/Laropiprant in Patients With Type 2 Diabetes (0524A-069)
Condition: Diabetes Mellitus Type 2
Interventions: Drug: ER niacin/laropiprant;   Drug: Comparator : placebo (unspecified)
3 Completed Lipid Efficacy Study (0524B-022)(COMPLETED)
Conditions: Primary Hypercholesterolemia;   Mixed Hyperlipidemia
Interventions: Drug: niacin (+) laropiprant (+) simvastatin;   Drug: Comparator: niacin (+) laropiprant;   Drug: Comparator: simvastatin
4 Completed Lipid Efficacy/Tolerability Study (0524A-020)
Conditions: Primary Hypercholesterolaemia;   Mixed Hyperlipidaemia
Interventions: Drug: niacin (+) laropiprant;   Drug: ER-niacin

Study has passed its completion date and status has not been verified in more than two years.